跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CLARATYNE REDITABS loratadine 10 mg orally disintegrating tablet blister pack (general sale)
Approved
STANDARD
CLARATYNE REDITABS loratadine 10 mg orally disintegrating tablet blister pack (general sale)
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
4775d65652ce1955
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
4775d65652ce1955
Product Name
CLARATYNE REDITABS loratadine 10 mg orally disintegrating tablet blister pack (general sale)
Artg Id
279809
Artg Name
CLARATYNE REDITABS loratadine 10 mg orally disintegrating tablet blister pack (general sale)
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2016-08-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
4775d65652ce1955
Type
Standard
Back to TGA Approvals
CLARATYNE REDITABS loratadine 10 mg orally disintegrating tablet blister pack (general sale) - TGA Drug Approval Details
